Marker Therapeutics Inc
NASDAQ:MRKR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Marker Therapeutics Inc
NASDAQ:MRKR
|
US |
|
Claritev Corp
NYSE:CTEV
|
US |
|
B
|
BoKwang Industry Co Ltd
KOSDAQ:225530
|
KR |
|
Z
|
Zalando SE
XHAN:ZAL
|
DE |
|
Mojave Brands Inc
F:0HC
|
CA |
|
P
|
Planisware SA
PAR:PLNW
|
FR |
|
M
|
Murata Manufacturing Co Ltd
XMUN:MUR1
|
JP |
|
S
|
Spur Corporation Ltd
JSE:SUR
|
ZA |
|
Shimizu Corp
TSE:1803
|
JP |
|
Buru Energy Ltd
ASX:BRU
|
AU |
|
I
|
Imagesat International ISI Ltd
TASE:ISI
|
IL |
|
K
|
Kbc Groep NV
SWB:KDB
|
BE |
|
M
|
Minebea Mitsumi Inc
F:MEA
|
JP |
|
O
|
OneJoon Co Ltd
KOSDAQ:382840
|
KR |
|
N
|
Next PLC
DUS:NXG
|
UK |
|
Ezaki Glico Co Ltd
F:5EJ
|
JP |
Bankruptcy Probability
Marker Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Marker Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Marker Therapeutics Inc
NASDAQ:MRKR
|
16.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
521.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
252.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
211.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
141.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
95.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
88.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Marker Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Marker Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.